Overview

Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers

Status:
Recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the similarity of major pharmacokinetic parameters after a single intravenous administration of JT1801 and NESP® in chinese healthy male volunteers. And to evaluate the safety, immunogenicity and pharmacodynamic characteristics of JT1801 and NESP® in chinese healthy male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Yi Fang